First Parkinson’s drug to treat hallucinations and delusions is approved

News

Author: AdminPublished: 6 May 2016

Prep: Cook: Serves:

A new antipsychotic drug to treat symptoms of psychosis associated with Parkinson’s disease like hallucinations and delusions has become the first to be approved by the FDA.

The drug, called Nuplazid (pimavanserin), is the first of its kind on the market for use by people living with Parkinson’s in the US. It works only on the serotonin system, meaning – unlike previous antipsychotic medication – it doesn’t worsen motor symptoms.

It is estimated that around half the people with the condition may at some point experience hallucinations (seeing things that aren’t there) or delusions (holding false, paranoid, beliefs), also referred to as psychosis.

Dr Mitchell Mathis, director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research, said: “Nuplazid represents an important treatment for people with Parkinson’s.”

Nuplazid is developed by Acadia Pharmaceuticals and will be available from June 2016 at the estimated annual cost of US$23,400.

Last Month

Next Month

Go Back

Share this story

Comments

Global update

6 works of art shedding light on Parkinson’s

How are artists around the world portraying Parkinson’s?

‘7 Years of Camera Shake’: photographer with Parkinson’s publishes inspiring coffee table book

David Plummer describes his journey as a wildlife photographer

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

Shedding light on the dementia often mistaken for Parkinson’s

Is dry eye disease common in people with Parkinson’s?

Dry eye disease can involve symptoms such as a lower blinking rate and typically occurs when the eyes are not effectively moistened by tears – leading to discomfort and possible vision loss. Now, a recent study from Japan has investigated the previously underexplored relationship between dry eye disease and Parkinson’s. As part of their research, the team analysed 13 studies published between 2004 and 2022, which involved more than 1,500 people with Parkinson’s. Five of the reports highlighted the prevalence of dry eye disease in people with the condition – with 61% experiencing symptoms. “Our findings emphasize the need for clinicians to be vigilant of the presence of dry eye disease when managing [people with Parkinson’s],” the researchers wrote. However, they noted that more research is needed – especially “future large-scale studies” – to help understand the relationship between dry eye disease and the condition.

Highlighting dental care needs among people with Parkinson’s disease

Researchers from the University of Copenhagen, Denmark, have published a new study looking into dental care among people with Parkinson’s. Using a national register to obtain data relating to dental care between 2015 and 2019, the team identified 6,874 people with Parkinson’s, whose data was then compared to a control group of 34,285 people without the condition. A key takeaway from the five-year study was that a larger portion of people with Parkinson’s were not regular users of the dental care system – 21%, compared to 16.9% in the control group. The findings published in the journal ‘Community Dentistry and Oral Epidemiology’ also revealed that people with Parkinson’s utilised more dental-related treatment services than those in the control group – such as fillings and extractions. The researchers concluded: “This knowledge can be used by clinicians and decision-makers to ensure the optimal dental care for persons with Parkinson’s.”

Could risk factors for Parkinson’s disease be “largely man-made”?

New research has highlighted evidence of a potential link between Parkinson’s risk and exposure to toxic environmental factors – including air pollutants and human-made materials. The research was presented at the 147th Annual Meeting of the American Neurological Association in Chicago, US, as part of a symposium on neurological disorders. The evidence included a study that highlighted that exposure to toxic pollutants may activate genes associated with the condition and that current environmental policies fail to consider the potential long-term effects of neurotoxic chemicals. “The world’s fastest-growing brain disease is largely man-made,” said neurologist Dr Ray Dorsey, one of the symposium speakers, in a press release. “The principal causes are toxic exposures to chemicals synthesised in the labs of chemical companies.” Calling for greater awareness surrounding the issue, he said: “If we educate the communities we’re supposed to serve, we can have them be mobilised and change the course of…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

First Parkinson’s drug to treat hallucinations and delusions is approved

News

Author: AdminPublished: 6 May 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

6 works of art shedding light on Parkinson’s

Perspectives

‘7 Years of Camera Shake’: photographer with Parkinson’s publishes inspiring coffee table book

Special reports

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

Is dry eye disease common in people with Parkinson’s?

Highlighting dental care needs among people with Parkinson’s disease

Could risk factors for Parkinson’s disease be “largely man-made”?

{title}

Subscribe

First Parkinson’s drug to treat hallucinations and delusions is approved

News

Author: AdminPublished: 6 May 2016

Last Month

Next Month

Share this story

Comments

Related articles

Global update

6 works of art shedding light on Parkinson’s

Perspectives

‘7 Years of Camera Shake’: photographer with Parkinson’s publishes inspiring coffee table book

Special reports

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

Is dry eye disease common in people with Parkinson’s?

Highlighting dental care needs among people with Parkinson’s disease

Could risk factors for Parkinson’s disease be “largely man-made”?

{title}

Subscribe

Sign in